` ISRG (Intuitive Surgical Inc) vs S&P 500 Comparison - Alpha Spread

ISRG
vs
S&P 500

Over the past 12 months, ISRG has significantly outperformed S&P 500, delivering a return of 41% compared to the S&P 500's 12% growth.

Stocks Performance
ISRG vs S&P 500

Loading
ISRG
S&P 500
Add Stock

Performance Gap
ISRG vs S&P 500

Loading
ISRG
S&P 500
Difference

Performance By Year
ISRG vs S&P 500

Loading
ISRG
S&P 500
Add Stock

Competitors Performance
Intuitive Surgical Inc vs Peers

Intuitive Surgical Inc
Glance View

Economic Moat
Wide
Market Cap
200.7B USD
Industry
Health Care

In the rapidly evolving landscape of medical technology, Intuitive Surgical Inc. stands as a pioneer, revolutionizing the way surgeries are performed through its groundbreaking robotic systems. Founded in 1995, the company has set the benchmark for minimally invasive surgery with its flagship product, the da Vinci Surgical System. This sophisticated platform integrates advanced robotics, 3D visualization, and intuitive controls to enable surgeons to perform intricate procedures with precision and control that far surpass conventional methods. By enhancing the dexterity of the human hand and allowing for remarkably steady movements, the system reduces the physical strain on surgeons while improving patient outcomes in terms of reduced recovery time, minimized scarring, and lower risk of infection. Intuitive Surgical’s business model is both innovative and practical, capitalizing on a combination of product sales, ongoing service agreements, and instrument and accessory sales. Initially, hospitals and medical centers invest significantly in acquiring the da Vinci Systems, providing Intuitive with substantial capital inflows. However, the true genius of the company's revenue model lies in its ecosystem approach; ongoing revenue is generated through the sale of disposable instruments and components needed for each surgery. Additionally, the firm offers extensive maintenance and support services, ensuring that healthcare providers maximize their return on investment while maintaining optimal performance of their surgical systems. This balanced model creates a consistent and reliable income stream, enhancing the company's financial stability and enabling it to invest continually in research and development.

ISRG Intrinsic Value
165.64 USD
Overvaluation 71%
Intrinsic Value
Price
Back to Top